MRSA infections are associated with more than 18,000 U.S. deaths each year.

Long-term therapy with pioglitazone in patients with cardiovascular disease and type 2 diabetes not only reduces risk of death, myocardial infarction, or stroke, but it also has favourable effects on lipid markers in patients on statin therapy

A new prospective cohort study shows that negative aspects of a close relationship–such as not confiding and not getting emotional support–can increase the risk of coronary events for both men and women.

Congestive heart failure in patients with prediabetes and type 2 diabetes given TZDs might not carry the risk that is usually associated with congestive heart failure.

According to a new study, Type 2 diabetes patients are at increased risk for cardiovascular disease (CVD), yet a novel therapy employing the use of ezetimibe/simvastatin offers this patient population the option of lowering not only LDL-C, but also non-HDL-C, apo-B, and hs-CRP.

A diet rich in antioxidant vitamins and minerals (vitamins A, C, and E, various carotenoids, and zinc) did nothing to prevent age-related macular degeneration, according to a large review and meta-analysis.

New inhaled insulin shows less glucose excursions after meals then injected insulin.

A new cholesterol experimental drug by Merck & Co., from the same class as the one that failed for Pfizer, had dramatic results in a small clinical trial, raising HDL by 39% and lowering LDL by 40% without the safety problems that killed the Pfizer product.

Heart disease and stroke account for about 65 percent of deaths in people with diabetes

A mix of acetaminophen and caffeine may cause liver damage, especially in heavy caffeine drinkers, according to a study at the University of Washington in Seattle.